Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

63.18
Delayed Data
As of Sep 01
 -1.23 / -1.91%
Today’s Change
47.36
Today|||52-Week Range
72.31
+9.86%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 79.50, with a high estimate of 100.00 and a low estimate of 63.00. The median estimate represents a +25.83% increase from the last price of 63.18.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.30
Sales
$4.8B
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.80%
 
 
 
 
 
 
Growthannually 4.54%
 
 
 
 
 
 

Sales

Growthquarterly -4.08%
 
 
 
 
 
 
Growthannually -4.14%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.